Nano TransMed is an open access peer-reviewed journal that aims to provide a forum to promote and accelerate the translation of preclinical nano research to a clinical application and the communication between researchers and clinicians in a timely manner.

The Journal embraces interdisciplinary and cross-boundary research and linkage between nano technology and clinical applications. Th emphasis is on hot or emerging innovative topics include preclinical applications of novel nanoscale materials, nano delivery system for stem cell-based therapy, nano fabrication and precise tissue engineering, as well as nanotechnology in pharmacology & pharmaceutics, diagnostics, targeted cancer therapy; translational outputs and evidence-based clinical outcomes of nano research. Non-nano works with significant potentials in future nanomedicine may be considered on a case by case basis.

The journal contains original research papers, review articles, technical notes, editorials, and letters to the editor about matters that may benefit the wider readership of Nano TransMed.

The editors welcome contributions on a variety of topics such as:

• Translational medicine;

• Nanomaterials;

• Nanomedicine;

• Nanodelivery system;

• Nano-fabrication;

• Tissue engineering;

• Natural product-based nanoparticles;

• Advanced manufacturing;

• Smart medical appliances and device;

• Stem cells;

• Exosomes and Extracellular Vesicles;

• Bioanalysis;

• Nanotechnology in pharmacology & pharmaceutics, diagnostics, targeted cancer therapy

Editorial Board